Jeremy N. Ruskin

Cardiology
27700 NW Freeway Ste 200
Cypress,, TX 77433

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 133 publications

Cerebral hypoperfusion and altered neuro-cardiorespiratory coupling in atrial fibrillation.

Cerebral hypoperfusion and altered neuro-cardiorespiratory coupling in atrial fibrillation.

Journal: medRxiv : the preprint server for health sciences
Published: July 30, 2026

Associations Between Objective Sleep Characteristics From Wearable Physiologic Monitors and Incident Atrial Fibrillation.

Associations Between Objective Sleep Characteristics From Wearable Physiologic Monitors and Incident Atrial Fibrillation.

Journal: JACC. Advances
Published: November 28, 2025

Association Between Mosaic Loss of Y Chromosome and Atrial Fibrillation.

Association Between Mosaic Loss of Y Chromosome and Atrial Fibrillation.

Journal: JACC. Clinical electrophysiology
Published: October 07, 2025

Supraventricular Tachycardia Burden on Ambulatory ECG Monitoring Predicts Recurrent Atrial Fibrillation Following Catheter Ablation for Atrial Fibrillation.

Supraventricular Tachycardia Burden on Ambulatory ECG Monitoring Predicts Recurrent Atrial Fibrillation Following Catheter Ablation for Atrial Fibrillation.

Journal: The American journal of cardiology
Published: July 16, 2025

Primum Non Nocere: The Onus to Characterize the Potential Harms of Psychedelic Treatment.

Primum Non Nocere: The Onus to Characterize the Potential Harms of Psychedelic Treatment.

Journal: The American journal of psychiatry
Published: January 01, 2025

Racial/Ethnic Disparities in Anticoagulation for Atrial Fibrillation by Sex and Within High and Low Stroke Risk Populations.

Racial/Ethnic Disparities in Anticoagulation for Atrial Fibrillation by Sex and Within High and Low Stroke Risk Populations.

Journal: The Journal of innovations in cardiac rhythm management
Published: December 12, 2024

Flecainide acetate inhalation solution for cardioversion of recent-onset, symptomatic atrial fibrillation: results of the phase 3 RESTORE-1 trial.

Flecainide acetate inhalation solution for cardioversion of recent-onset, symptomatic atrial fibrillation: results of the phase 3 RESTORE-1 trial.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
Published: September 03, 2024

Cardiovascular effects and safety of classic psychedelics.

Cardiovascular effects and safety of classic psychedelics.

Journal: Nature cardiovascular research
Published: June 14, 2024

Nationwide Trends in Hospitalizations for Atrial Fibrillation and Flutter in the United States before and during the Outbreak of the COVID-19 Pandemic.

Nationwide Trends in Hospitalizations for Atrial Fibrillation and Flutter in the United States before and during the Outbreak of the COVID-19 Pandemic.

Journal: Journal of clinical medicine
Published: May 31, 2024

Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm: INSTANT Phase 2 Trial.

Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm: INSTANT Phase 2 Trial.

Journal: JACC. Clinical electrophysiology
Published: September 21, 2023

Outcomes of Patients With Takotsubo Syndrome Compared With Type 1 and Type 2 Myocardial Infarction.

Outcomes of Patients With Takotsubo Syndrome Compared With Type 1 and Type 2 Myocardial Infarction.

Journal: Journal of the American Heart Association
Published: September 08, 2023

Single- Versus Dual-Chamber Implantable Cardioverter-Defibrillator for Primary Prevention of Sudden Cardiac Death in the United States.

Single- Versus Dual-Chamber Implantable Cardioverter-Defibrillator for Primary Prevention of Sudden Cardiac Death in the United States.

Journal: Journal of the American Heart Association
Published: July 31, 2023
Showing 1-12 of 133

Last Updated: 09/26/2026